FDA Inspection
Pharmacyclics LLCPharmacyclics LLC – FDA Inspection, Apr 27, 2022
Record Details
This FDA Inspection record concerns Pharmacyclics LLC, with an inspection on April 27, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Pharmacyclics LLC
- Inspection Date
- April 27, 2022
- Product Type
- Drugs
View Company Profile
ID · bb0d83c2-65e5-4cda-b89e-e5cac46dd280
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1169285
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.56(c)IND safety report
- 21 CFR 312.52(a)Transfer of obligations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Pharmacyclics LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 11, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 11, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Pharmacyclics LLC
- FDA Inspection 1010437 - 2017-03-24
- FDA Inspection 909656 - 2014-12-05
- FDA Inspection 853597 - 2013-10-11
- FDA Inspection 849761 - 2013-09-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.